Pharmicell Capital Reinvestment Ratio
Pharmicell capital reinvestment ratio. Pharmicell (005690) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩8.78 Billion) in capital expenditures (₩622.48 Million). Check Pharmicell cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Pharmicell (2016–2024)
Capital reinvestment ratio of Pharmicell from 2016 to 2024. This chart tracks Pharmicell's Capital Reinvestment Ratio across 6 annual periods. Also explore Pharmicell (005690) net asset momentum to track the company's year-over-year net asset growth rate.
Pharmicell Capital Reinvestment Ratio by Year (2016–2024)
Pharmicell capital reinvestment ratio by year from 2016 to 2024. For the full cash flow conversion analysis, see Pharmicell (005690) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.24x | ₩3.50 Billion | ₩4.34 Billion | ▲ +143.3% |
| 2023 | 0.51x | ₩11.81 Billion | ₩6.02 Billion | ▼ -78.7% |
| 2022 | 2.40x | ₩7.91 Billion | ₩18.96 Billion | ▲ +2795.5% |
| 2020 | 0.08x | ₩8.98 Billion | ₩742.73 Million | ▼ -94.0% |
| 2018 | 1.37x | ₩3.40 Billion | ₩4.68 Billion | ▼ -64.7% |
| 2016 | 3.89x | ₩988.97 Million | ₩3.85 Billion | — |